Anzeige
Mehr »
Login
Donnerstag, 09.01.2025 Börsentäglich über 12.000 News von 682 internationalen Medien
GameStop 2.0? ...alle Anzeichen für den nächsten großen Short Squeeze!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
304 Leser
Artikel bewerten:
(1)

Fermín Serna Joins Databricks as Chief Security Officer

Finanznachrichten News

Former Citrix and Google security executive brings decades of deep technical knowledge to the high-growth pioneer of the data lakehouse

SAN FRANCISCO, Aug. 19, 2021 /PRNewswire/ -- Databricks, the Data and AI company, today announced the appointment of longtime software executive and seasoned security chief, Fermín Serna, as the company's new Chief Security Officer (CSO). Serna will lead Databricks' high-impact network, platform and user security programs along with governance and compliance efforts as the company expands its platform capabilities and positions itself for the next phase of growth.

Databricks Logo

"For Databricks and our customers across the globe, security is paramount and I am thrilled to welcome Fermín to the team as our Chief Security Officer," said Ali Ghodsi, CEO and Co-Founder of Databricks. "Fermín's deep technical knowledge and impressive experience building and leading best-in-class security teams will prove invaluable for Databricks' next chapter."

Serna brings over 20 years of enterprise information security expertise to the Databricks leadership team and will oversee the expansion of the organization's mission-critical cybersecurity organization. He joins Databricks from Citrix, where he most recently led a robust global security and data privacy practice as the Chief Information Security Officer (CISO).

Prior to this, Serna also served as the Head of Product Security at Google. In this role, he led the team responsible for Google Product Security and worked closely with external technology partners to build highly secure APIs, development libraries and containment frameworks to ensure Google security standards were met at every turn of the product lifecycle. During his tenure at Google, he worked to establish and implement security review practices and also oversaw the vulnerability response and risk mitigation protocols for several product groups. Serna has also held senior security roles at Microsoft and was previously the CSO for Semmle (acquired by GitHub), where he established and led the security research and vulnerability response teams.

"Databricks is at the forefront of data and AI innovation as it pioneers the new lakehouse category and I am incredibly excited to join the leadership team during such a pivotal time," said Serna. "I look forward to working with customers, partners and the world class Databricks security team as we bring the company and product vision to new heights."

About Databricks
Databricks is the data and AI company. More than 5,000 organizations worldwide - including Comcast, Condé Nast, H&M, and over 40% of the Fortune 500 - rely on the Databricks Lakehouse Platform to unify their data, analytics and AI. Databricks is headquartered in San Francisco, with offices around the globe. Founded by the original creators of Apache Spark, Delta Lake and MLflow, Databricks is on a mission to help data teams solve the world's toughest problems. To learn more, follow Databricks on Twitter, LinkedIn and Facebook.

Press Contact:
Press@databricks.com

Logo - https://mma.prnewswire.com/media/1160675/Databricks_Logo.jpg

© 2021 PR Newswire
Gewinner im Megamarkt
Biotechnologie ist eine der bedeutendsten Zukunftstechnologien unserer Zeit. Zahlreiche Biotechnologie- und Pharmakonzerne haben sich unter anderem dem Kampf gegen Tumorerkrankungen verschrieben. Der weltweite Markt für Krebsmedikamente verzeichnet ein stetiges Wachstum. Für das Jahr 2025 wird ein Umsatz von etwa 190,3 Milliarden Euro prognostiziert, mit einer erwarteten jährlichen Wachstumsrate von 6,42% bis 2029, was zu einem geschätzten Marktvolumen von 244,1 Milliarden Euro führen würde.

Wir haben 3 aussichtsreiche Biotechnologieaktien mit Schwerpunkt Erforschung und Entwicklung von Wirkstoffen gegen Tumorerkrankungen ausfindig gemacht, die in den kommenden Monaten und Jahren erhebliches Aufwärtspotenzial versprechen und Vervielfachungspotenzial besitzen.

Fordern Sie jetzt unseren neuen kostenlosen Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien durchstarten und zu Ihrem Börsenerfolg in 2025 beitragen könnten!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.